410 related articles for article (PubMed ID: 23345608)
1. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
[TBL] [Abstract][Full Text] [Related]
2. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
Yegnasubramanian S; Wu Z; Haffner MC; Esopi D; Aryee MJ; Badrinath R; He TL; Morgan JD; Carvalho B; Zheng Q; De Marzo AM; Irizarry RA; Nelson WG
BMC Genomics; 2011 Jun; 12():313. PubMed ID: 21669002
[TBL] [Abstract][Full Text] [Related]
3. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
8. HIC1 modulates prostate cancer progression by epigenetic modification.
Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
[TBL] [Abstract][Full Text] [Related]
10. DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation.
Rauluseviciute I; Drabløs F; Rye MB
BMC Med Genomics; 2020 Jan; 13(1):6. PubMed ID: 31914996
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.
Silva R; Moran B; Baird AM; O'Rourke CJ; Finn SP; McDermott R; Watson W; Gallagher WM; Brennan DJ; Perry AS
Clin Epigenetics; 2021 Aug; 13(1):168. PubMed ID: 34454584
[TBL] [Abstract][Full Text] [Related]
12. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
13. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
Yegnasubramanian S; De Marzo AM; Nelson WG
Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
[TBL] [Abstract][Full Text] [Related]
15. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of the ITGB4 gene in prostate cancer.
Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
[TBL] [Abstract][Full Text] [Related]
17. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.
Kumar A; Coleman I; Morrissey C; Zhang X; True LD; Gulati R; Etzioni R; Bolouri H; Montgomery B; White T; Lucas JM; Brown LG; Dumpit RF; DeSarkar N; Higano C; Yu EY; Coleman R; Schultz N; Fang M; Lange PH; Shendure J; Vessella RL; Nelson PS
Nat Med; 2016 Apr; 22(4):369-78. PubMed ID: 26928463
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation in prostate cancer.
Park JY
Cancer Control; 2010 Oct; 17(4):245-55. PubMed ID: 20861812
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation changes in prostate cancer.
Goering W; Kloth M; Schulz WA
Methods Mol Biol; 2012; 863():47-66. PubMed ID: 22359287
[TBL] [Abstract][Full Text] [Related]
20. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
